4//SEC Filing
Myers Michael 4
Accession 0001104659-24-097254
CIK 0001671502other
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 12:03 PM ET
Size
10.5 KB
Accession
0001104659-24-097254
Insider Transaction Report
Form 4
Myers Michael
DirectorChief Executive Officer
Transactions
- Purchase
Ordinary Shares
2024-09-03$0.62/sh+800$495→ 10,158 total - Purchase
Ordinary Shares
2024-09-04$0.66/sh+5,322$3,490→ 15,480 total - Purchase
Ordinary Shares
2024-09-04$0.75/sh+8,200$6,134→ 23,680 total - Purchase
Ordinary Shares
2024-09-04$0.80/sh+23,572$18,796→ 47,252 total
Footnotes (2)
- [F1]Reported securities are represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer.
- [F2]Effective July 18, 2023, the ratio of ADSs evidencing ordinary shares changed from 1 ADS representing five thousand (5,000) ordinary shares to 1 ADS representing sixty thousand (60,000) ordinary shares, which resulted in a 1 for 12 reverse split of the issued and outstanding ADSs. Effective November 8, 2023, the Issuer completed a 1 for 60,000 reverse split of the ordinary shares which resulted in the ratio of ADSs evidencing ordinary shares to be changed from 1 ADS representing sixty thousand (60,000) ordinary shares to 1 ADS representing one (1) ordinary share. The amount of ordinary shares reported in this column includes ordinary shares previously included in the Reporting Person's Form 3, adjusted to reflect the number of ordinary shares resulting from the 1 for 60,000 reverse split effective November 8, 2023.
Documents
Issuer
Quoin Pharmaceuticals, Ltd.
CIK 0001671502
Entity typeother
Related Parties
1- filerCIK 0001959547
Filing Metadata
- Form type
- 4
- Filed
- Sep 4, 8:00 PM ET
- Accepted
- Sep 5, 12:03 PM ET
- Size
- 10.5 KB